✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologyResearchSafetyMental Health Why This Matters Clinicians need to assess substance use patterns in younger stroke...
Recreational drugs can more than double risk of stroke, study suggests – The Guardian
✦ New CED Clinical Relevance #72 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyNeurologyMental Health Why This Matters Clinicians need to counsel patients that cannabis use carries a...
Study highlights stroke risk linked to recreational drugs, including among young users
✦ New CED Clinical Relevance #75 Strong Clinical Relevance High-quality evidence with meaningful patient or clinical significance. NeurologyResearchSafetyMental Health Why This Matters Clinicians need to recognize cannabis as a modifiable stroke risk...
Daily Digest: Last 9 Hours: Stroke Risk From Recreational Drugs and DEA Scheduling Actions — March 08, 2026
A synthesis of 12 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
Recreational drugs triple the risk of stroke in young people, study finds | The Independent
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. NeurologySafetyResearchMental Health Why This Matters Clinicians treating young patients with stroke should screen for recreational...
Daily Digest: Last 38 Hours: Cannabinoids, Liver Disease, and the Adolescent Brain — March 08, 2026
A synthesis of 82 recently added cannabis articles — key themes, clinical context, and Dr. Caplan’s take.
In the Mix: 20 More Articles — March 08, 2026
20 cannabis articles scored below the CED clinical relevance threshold in the last 24 hours. Summaries and source links included.
Cannabis industry overhaul under way to unlock multibillion-rand sector – Business Day
✦ New CED Clinical Relevance #35 Clinical Context Background information relevant to the evolving cannabis medicine landscape. PolicyResearchHempIndustry Why This Matters South Africa’s cannabis sector expansion and research facility development could improve...
New study reveals surprising benefit of GLP-1s that has nothing to do with weight loss
✦ New CED Clinical Relevance #45 Clinical Context Background information relevant to the evolving cannabis medicine landscape. ResearchMental HealthSafetyNeurology Why This Matters Clinicians prescribing GLP-1 receptor agonists should be aware that these...
Youth and cannabis: What’s the risk? – The Lewiston Tribune
✦ New CED Clinical Relevance #65 Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ResearchSafetyPediatricsMental HealthPolicy Dr. Caplan’s Take “We simply don’t have the longitudinal data we need to...